Archives

by in
Entry Author Date Location
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
Avelas Closes Round, Advancing Biologic That Illuminates Breast Cancer 09/10/14 San Diego
East Coast Biotech Roundup: Infinity, Merck, Voyager, Ebola, & More 09/05/14 Boston
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
Texas Roundup: New Funds for Bellicum, AirStrip, and Green & Grow 08/28/14 Texas
Houston’s Bellicum Nets $55M to Boost Trials for Cancer Treatment 08/27/14 Texas
Texas Roundup: CPRIT, Saranas, SailPoint, Leto Solutions, Bearch 08/22/14 Texas
Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer 08/22/14 San Diego
Sanford-Burnham Seeks Improved Pharma Ties with New CEO from GSK 08/19/14 San Diego
Cellectar Biosciences Makes Nasdaq Debut With $12.5M Stock Offering 08/15/14 Wisconsin
Texas Roundup: New funds for Castle, Quarri, Omni Water, & Pivot3 08/14/14 Texas
Houston Cancer Diagnostics Firm Castle Biosciences Raises $11.8M 08/13/14 Texas
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More 08/07/14 San Diego
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
DiBS’s BioWheel Aims to Paint a Dynamic Picture of Life Sciences Data 08/01/14 Texas
Epic Sciences Raises $30M to Advance Cancer Diagnostics 07/30/14 San Diego
West Coast Biotech Roundup: IPOs, Gilead, Sofinnova, & Denouements 07/25/14 San Diego
Cypher Genomics’ Analytics Tech Gains Some Cred in Illumina Deal 07/24/14 San Diego
Gilead Edges Into Cancer Field With FDA OK of Calistoga Drug 07/23/14 San Francisco
Cellectar, an OTC Stock, Eyes Nasdaq Jump to Boost Profile, Prospects 07/22/14 Wisconsin
How Seragon CEO Rich Heyman Made Lightning Strike Twice 07/16/14 San Diego
CPRIT Executives Outline Cancer-Fighting Priorities in Houston Visit 07/14/14 Texas
New Jounce CEO Aims to Place the Right Immuno-Oncology Bets 07/11/14 Boston
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More 07/03/14 San Diego
VenBio Scores Again as Genentech Pays $1.7B+ for Seragon Pharma 07/02/14 San Diego
BIO 2014: Innovations in 3-D Tissue for Disease and Drug Discovery 06/26/14 San Diego
BIO 2014: Antisense and Disruptive Technologies for Drug Discovery 06/23/14 San Diego
Sanofi Punts Cancer Drug Back to Merrimack 06/19/14 Boston
BIO 2014: An Industry Surrounded by Insurmountable Opportunity 06/19/14 San Diego
Page 1 of 56 next page »